GLGlobe Life Inc. presents a strong fundamental profile with consistent profitability and a stable business model in the insurance sector. While valuation metrics are reasonable, its growth might be more moderate compared to high-growth tech sectors. Technicals show a generally positive trend but with some caution on short-term indicators.
Operating in the insurance and financial services sector, Globe Life benefits from stable demand for its products. Emerging trends like digital transformation in insurance and increased demand for financial security are supportive, but it doesn't ride major high-growth tech themes like AI or cloud computing.
Globe Life demonstrates strong financial health with healthy profit margins, consistent earnings growth, and a robust balance sheet. Its dividend yield is attractive for income-focused investors.
The stock has shown strong performance over the past year, trading above key moving averages. However, some short-term oscillators suggest it may be nearing overbought conditions, hinting at a potential for consolidation.
| Factor | Score |
|---|---|
| Insurance Sector Demand | 80 |
| Digital Transformation in Insurance | 60 |
| Financial Security & Stability | 75 |
| Interest Rate Sensitivity | 50 |
| Regulatory Landscape | 55 |
| Factor | Score |
|---|---|
| Valuation | 80 |
| Profitability | 85 |
| Growth | 70 |
| Balance Sheet Health | 75 |
| Cash Flow | 85 |
| Dividend Yield | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 80 |
| Momentum | 70 |
| Volume Confirmation | 70 |
| Support & Resistance | 60 |
| Short-term Performance | 75 |
Attractive P/E Ratio
The Price-to-Earnings (P/E) ratio of 13.4 (TTM) is relatively low compared to historical averages and industry peers, suggesting potential undervaluation.
Consistent EPS Growth
The company has consistently met or exceeded earnings per share (EPS) estimates in recent quarters, with a positive surprise percentage in most periods, indicating robust earnings power.
Increasing P/S Ratio
The Price-to-Sales (P/S) ratio has increased from 1.5 in 2021 to 2.0 in 2023, potentially indicating that the stock is becoming more expensive relative to its revenue.
EPS Misses
There have been instances of the company missing EPS estimates (e.g., Q2 2025 estimate vs. reported), which could signal potential future earnings headwinds.
July 2025
3
Ex-Dividend Date
August 2025
1
Next Dividend Date
October 2025
23
Next Earnings Date
H: $4.45
A: $3.98
L: $3.46
H: 1.52B
A: 1.52B
L: 1.51B
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products. The company sells its products through its direct-to-consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
148.64 USD
The 39 analysts offering 1 year price forecasts for GL have a max estimate of 188.00 and a min estimate of 114.00.